AltMountain

Sands Capital Life Sciences Pulse Fund-GP, L.P.

Arlington, VA · CIK 1781279
Status: no Form D since Jul 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Sands Capital Life Sciences Pulse Fund-GP, L.P. is a private equity fund based in Arlington, Virginia. According to its most recent Form D, filed Jul 7, 2020, it has sold $1,130,000 of interests to 18 investors since its first sale in Jun 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Stephen Zachary; Erin Soule; Jonathan Goodman.

Total raised
$1,130,000Cumulative sales reported on Form D
Investors
18
First sale
Jun 25, 2019
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Stephen Zachary; Erin Soule; Jonathan Goodman
Latest Form D
Jul 7, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Jul 7, 2020Form D/A (amendment)$1,130,00018SEC.gov ↗
Jul 3, 2019Form D$565,00013SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 3, 2019. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Sands Capital Life Sciences Pulse Fund-GP, L.P.

What is the minimum investment for Sands Capital Life Sciences Pulse Fund-GP, L.P.?

Sands Capital Life Sciences Pulse Fund-GP, L.P.'s latest Form D, filed Jul 7, 2020, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Sands Capital Life Sciences Pulse Fund-GP, L.P.?

Sands Capital Life Sciences Pulse Fund-GP, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Sands Capital Life Sciences Pulse Fund-GP, L.P. raised?

Sands Capital Life Sciences Pulse Fund-GP, L.P. reports $1,130,000 sold from 18 investors on its Form D filed Jul 7, 2020. This is cumulative sales since the offering began, not current assets or performance.

Where is Sands Capital Life Sciences Pulse Fund-GP, L.P. based?

Sands Capital Life Sciences Pulse Fund-GP, L.P. is based in Arlington, Virginia.

When did Sands Capital Life Sciences Pulse Fund-GP, L.P. launch?

Sands Capital Life Sciences Pulse Fund-GP, L.P. reports its first sale in Jun 2019.

Size compared with every private equity fund

Raised more than 48% of the 206 private equity funds based in Virginia, and more than 22% of all 8,983 that report sales.

Other funds with the same team

More private equity funds in Arlington

Similar-size private equity funds in Virginia

All private equity funds in Virginia